Chemed (CHE) Aktsia Kursus
Chemed Kursus
Käive kasvas 4,9 % aastas viimase 19 aasta jooksul 2,53 B USD-ni. Kasum aktsia kohta kasvas 12,7 % aastas viimase 19 aasta jooksul. Chemed netomarginaal on nüüd 10,5 %, langenud 12,6 %-lt mõni aasta tagasi. Chemed pakub praegu umbes 0,42 % dividenditootlust. Väljamaksesuhe on umbes 12 % kasumist. Dividend kasvas 12,4 % aastas viimase 19 aasta jooksul. Analüütikute hinnasihi mediaan on 554,00 USD, st üle praegust hinda 4,9 %. 9 analüütikust 6 soovitab osta — üldine konsensus on Osta.
Chemed aktsiahinnad
Hangi need andmed Eulerpool API kaudu
100 000 päringut/kuus tasuta · krediitkaarti pole
Chemed ärimudel ja aktsia analüüs
Korduma kippuvad küsimused Chemed aktsia kohta
The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.
Chemed Corp is primarily active in the healthcare and service industries.
The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.
Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.
Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.
Chemed Corp is primarily present in the United States.
Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.
Analüütikud määravad Chemed aktsiale keskmiseks hinnasihi 554,00 USD (mediaan: 554,00 USD), mis on +4,9 % viimase hinna suhtes. Konsensus põhineb 9 analüütiku hinnangul.
9 analüütikut hindavad praegu Chemed aktsiat: 6 soovitab osta, 3 hoida ja 0 müüa. 2026. aastaks ootavad analüütikud, et Chemed teenib tulu 2,73 B USD ja kasumit aktsia kohta 27,97 USD.
Praeguse kursiga kaubeldakse Chemed aktsiaga 471,26 EUR (528,05 USD) juures.
Chemed aktsia (CHE) on noteeritud 2 börsil, sh: NYSE (CHE), Frankfurt (CXM.F).
Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.
oodatav Chemed käive on 2,73 B USD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.
oodatav Chemed kasum on 391,42 M USD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.
Võrdlusarvud hinna ja kasumiga (P/E) Chemed jaoks on praegu 18,88. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Chemed aktsia väärtust.
Kursuse ja müügimahu suhe (P/S) Chemed jaoks on praegu 2,70. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Chemed aktsia jaoks.
Eulpooli kvaliteedinäitaja Chemed jaoks on 8/10.
Chemed ISIN on US16359R1032. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.
Chemed WKN on A0CBF4. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.
Chemed ticker on CHE. Ticker-sümbol kasutatakse Chemed aktsiate kauplemiseks börsil.
Chemed aktsia
Chemed konkurendid
Chemed Börsiticker
Chemed FIGI
Kõik teised näitajad ja analüüsid Chemed kohta sügavamalt
Meie Chemed-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Chemed. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: